Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rang in Aktien #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Aktienkurs
$137.21
Marktkapitalisierung
$170.34B
Veränderung (1 Tag)
-2.76%
Veränderung (1 Jahr)
28.14%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Kategorie

EPS für Gilead Sciences, Inc. (GILD)
EPS zum December 2025 TTM: $6.85
Laut den aktuellen Finanzberichten und dem Aktienkurs von Gilead Sciences, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $6.85. Am Ende des Jahres 2024 betrug das EPS $0.38 ein Rückgang im Vergleich zu dem EPS von 2023, das $4.54 betrug.
EPS-Verlauf von Gilead Sciences, Inc. von 2000 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $6.85 0.15%
2025 $6.84 1,700.00%
2024 $0.38 -91.63%
2023 $4.54 24.04%
2022 $3.66 -26.21%
2021 $4.96 4,966.39%
2020 $0.10 -97.69%
2019 $4.24 0.95%
2018 $4.20 18.64%
2017 $3.54 -64.88%
2016 $10.08 -18.51%
2015 $12.37 55.60%
2014 $7.95 295.52%
2013 $2.01 17.54%
2012 $1.71 -5.52%
2011 $1.81 6.47%
2010 $1.70 16.44%
2009 $1.46 33.94%
2008 $1.09 25.29%
2007 $0.87 -233.85%
2006 $-0.65 -244.44%
2005 $0.45 73.08%
2004 $0.26 -680.36%
2003 $-0.04 -196.76%
2002 $0.05 32.29%
2001 $0.04 -189.74%
2000 $-0.04 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$23.00 235.77%
US
$13.20 92.70%
GB
$11.10 62.04%
US
$2.37 -65.40%
US
$7.20 5.11%
CH